Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Onco C4 Appoints Steve Chen As General Counsel
PRIVATESep 01, 2026•7 days ago
Position
General Counsel
Company
OncoC4
Steve Chen
RockvilleBiotechnology
Description
OncoC4, Inc. has announced the appointment of Steve Chen, JD, PhD, as their new General Counsel. Dr
Company Information
Company
OncoC4
Location
Rockville, Maryland, United States
About
OncoC4 is a privately held, late-stage biopharmaceutical company engaged in the discovery and development of novel biologicals for treating cancer and immunological diseases. Its pipeline features assets with first-in-class and best-in-class potential. AI-081 is a potentially best-in-class bispecific antibody candidate currently enrolling patients in a Phase 1/2 trial. OncoC4 also has a collaboration with BioNTech to co-develop gotistobart.
Don't miss OncoC4's next move
Get an email the moment OncoC4 changes its leadership, hires an exec, or expands, usually minutes after it happens.